𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

✍ Scribed by Flowers, M E D; Campregher, P V; Gooley, T; Scott, B L; Moravec, C; Sandmaier, B; Martin, P J; Deeg, H J; Warren, E H


Book ID
110015465
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
152 KB
Volume
40
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Donor cell myelodysplastic syndrome afte
✍ Rami Komrokji; Jainulabdeen J. Ifthikharuddin; Raymond E. Felgar; Camille N. Abb πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 1 views

## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to re‐emergence of a recipient derived, neoplastic, stem cell clone